MedTrace Logo

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

NCT07248371 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6266

Last updated 2025-11-25

No results posted yet for this study

Summary

This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.

Conditions

  • Metabolic Syndrome (MetS)
  • Obesity & Overweight
  • Cardiovascular Diseases (CVD)
  • Chronic Kidney Disease
  • Nonalcoholic Fatty Liver Disease
  • Healthy

Interventions

OTHER

No intervention

no intervention

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-09
Primary Completion
2028-09-30
Completion
2035-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07248371 on ClinicalTrials.gov